FDA

Regulatory Opinion: Year in Review

Regulatory Opinion: Year in Review

We feature our top opinion posts from 2012.

The Regulatory Blame Game

The Regulatory Blame Game

Criticism of FDA over meningitis outbreak repeats a familiar pattern of regulatory blame.

Week in Review

Week in Review

Political leaders call for stronger gun regulation, FDA chief pushes for specialty pharmacy rules, and more.

Week in Review

Week in Review

CFPB signs data deal with DOJ, EU opposes Internet regulation, and more.

Week in Review

Week in Review

British Petroleum agrees to billion-dollar oil spill settlement, FDA asks for legislation on compounding pharmacies, and more.

FDA Further Appeals Loss over Graphic Tobacco Packages Regulation

FDA Further Appeals Loss over Graphic Tobacco Packages Regulation

Agency seeks further review of lower court decision on graphic warnings rule.

Week in Review

Week in Review

Legislators seek answers on meningitis outbreak, business groups sue SEC over Dodd-Frank disclosure rule, and more.

Week in Review

Week in Review

White House group requests speedier drug approval, report details advantages of carbon tax, and more.

Report Highlights Difficulties with Regulating Federal Grants

Report Highlights Difficulties with Regulating Federal Grants

GAO identifies oversight challenges in administering federal grants to state and local governments.

FDA Finds Arsenic in Many Rice Products

FDA Finds Arsenic in Many Rice Products

Federal food safety agency says cutting rice consumption would be premature.

PPR Announces Fall 2012 Risk Regulation Series

PPR Announces Fall 2012 Risk Regulation Series

Three seminars will offer critical insights into regulation’s impact on business and society.

Proposition 37: Science, Law, and Consumer Protection

Proposition 37: Science, Law, and Consumer Protection

Californians will vote on whether to require the labeling of foods containing genetically modified products.